Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Regulatory Toxicology and Pharmacology : RTP
|
March 28, 2024
Species differences in specific ligand-binding affinity and activation of AHR: The biological basis for calculation of relative effective potencies and toxic equivalence factors
David L Eaton, Ted W Simon, Norbert E Kaminski, et al.
Regulatory Toxicology and Pharmacology : RTP
|
February 7, 2015
An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity--proof of concept
Richard A Becker, Katie Paul Friedman, Ted W Simon, et al.
Regulatory Toxicology and Pharmacology : RTP
|
September 4, 2017
How well can carcinogenicity be predicted by high throughput "characteristics of carcinogens" mechanistic data?
Richard A Becker, David A Dreier, Mary K Manibusan, et al.
Chemico-Biological Interactions
|
February 6, 2025
Calibration and evaluation of a refined pharmacokinetic model for three homologs of phosphatidylethanol
Ted W Simon, Brett Ginsburg, Martin A Javors, et al.
Critical Reviews in Toxicology
|
July 30, 2014
The use of mode of action information in risk assessment: quantitative key events/dose-response framework for modeling the dose-response for key events
Ted W Simon, S Stoney Simons, R Julian Preston, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
December 6, 2017
In vitro to in vivo extrapolation for high throughput prioritization and decision making
Shannon M Bell, Xiaoqing Chang, John F Wambaugh, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Regulatory Toxicology and Pharmacology : RTP
|
March 28, 2024
Species differences in specific ligand-binding affinity and activation of AHR: The biological basis for calculation of relative effective potencies and toxic equivalence factors
David L Eaton, Ted W Simon, Norbert E Kaminski, et al.
Regulatory Toxicology and Pharmacology : RTP
|
February 7, 2015
An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity--proof of concept
Richard A Becker, Katie Paul Friedman, Ted W Simon, et al.
Regulatory Toxicology and Pharmacology : RTP
|
September 4, 2017
How well can carcinogenicity be predicted by high throughput "characteristics of carcinogens" mechanistic data?
Richard A Becker, David A Dreier, Mary K Manibusan, et al.
Chemico-Biological Interactions
|
February 6, 2025
Calibration and evaluation of a refined pharmacokinetic model for three homologs of phosphatidylethanol
Ted W Simon, Brett Ginsburg, Martin A Javors, et al.
Critical Reviews in Toxicology
|
July 30, 2014
The use of mode of action information in risk assessment: quantitative key events/dose-response framework for modeling the dose-response for key events
Ted W Simon, S Stoney Simons, R Julian Preston, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
December 6, 2017
In vitro to in vivo extrapolation for high throughput prioritization and decision making
Shannon M Bell, Xiaoqing Chang, John F Wambaugh, et al.
Page
of 2